Pulmonary Hypertension Trial, Recruiting (NCT07120789)

Pulmonary Hypertension Trial, Recruiting NCT07120789 Sponsor: University of Sao Paulo General Hospital Condition: Pulmonary Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT07120789 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pulmonary Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 years or older
People who have been formally diagnosed with Group 1 Pulmonary Arterial Hypertension (PAH), which is a specific type of high blood pressure affecting the arteries in the lungs
People who are able to read and understand the language used in the study questionnaire
People who have given their formal written agreement (informed consent) to take part in the study
For one specific phase of the study (content validation): medical or academic professionals with recognised expertise in pulmonary hypertension may also be eligible to participate as expert reviewers

Who may not be able to join:

People with cognitive (thinking or memory), visual, or hearing difficulties that would make it hard to understand or complete the questionnaire
People who decline to participate or who have withdrawn their earlier agreement to take part
People whose health condition is currently too unstable to allow them to complete the questionnaire

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +55 11 2661 5034

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07120789

Sponsor: University of Sao Paulo General Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Pulmonary Hypertension

Trial contact: +55 11 2661 5034

More information: https://clinicaltrials.gov/study/NCT07120789

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 years or older
People who have been formally diagnosed with Group 1 Pulmonary Arterial Hypertension (PAH), which is a specific type of high blood pressure affecting the arteries in the lungs
People who are able to read and understand the language used in the study questionnaire
People who have given their formal written agreement (informed consent) to take part in the study
For one specific phase of the study (content validation): medical or academic professionals with recognised expertise in pulmonary hypertension may also be eligible to participate as expert reviewers

Who may not be able to join:

People with cognitive (thinking or memory), visual, or hearing difficulties that would make it hard to understand or complete the questionnaire
People who decline to participate or who have withdrawn their earlier agreement to take part
People whose health condition is currently too unstable to allow them to complete the questionnaire

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Sao Paulo General Hospital

Registry

ClinicalTrials.gov

Start date

1 September 2025

Est. completion

1 December 2026

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Content Validity Index (CVI) of the Questionnaire Items; Semantic Clarity Rating by Patients; Internal Consistency of the Questionnaire (Cronbach's Alpha)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov